HMGXB4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.247000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.830200E-01
Normal-vs-Stage2
8.452400E-01
Normal-vs-Stage3
1.018170E-01
Normal-vs-Stage4
4.185000E-01
Stage1-vs-Stage2
4.689600E-01
Stage1-vs-Stage3
8.683700E-02
Stage1-vs-Stage4
4.435000E-01
Stage2-vs-Stage3
1.185970E-01
Stage2-vs-Stage4
7.178300E-02
Stage3-vs-Stage4
6.910100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.803200E-01
Normal-vs-AfricanAmerican
8.442400E-01
Normal-vs-Asian
9.034600E-01
Caucasian-vs-AfricanAmerican
4.867400E-01
Caucasian-vs-Asian
8.243000E-01
AfricanAmerican-vs-Asian
7.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.188800E-01
Normal-vs-Female
9.534800E-01
Male-vs-Female
2.705200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.836190E-01
Normal-vs-Age(41-60Yrs)
8.796800E-01
Normal-vs-Age(61-80Yrs)
7.383200E-01
Normal-vs-Age(81-100Yrs)
6.294000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.320370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.714000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.017200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.659500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.270800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.191600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.533800E-01
Normal-vs-Daily Drinker
3.466600E-01
Normal-vs-Weekly Drinker
9.039200E-01
Normal-vs-Occasional Drinker
6.398400E-01
Normal-vs-Social Drinker
9.081600E-01
Non Drinker-vs-Daily Drinker
4.025200E-01
Non Drinker-vs-Weekly Drinker
4.777800E-01
Non Drinker-vs-Occasional Drinker
3.604100E-02
Non Drinker-vs-Social Drinker
4.593400E-01
Daily Drinker-vs-Weekly Drinker
2.125000E-01
Daily Drinker-vs-Occasional Drinker
1.443790E-02
Daily Drinker-vs-Social Drinker
1.988430E-01
Weekly Drinker-vs-Occasional Drinker
3.093800E-01
Weekly Drinker-vs-Social Drinker
9.913800E-01
Occasional Drinker-vs-Social Drinker
3.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.424200E-01
Normal-vs-Grade 2
2.429400E-01
Normal-vs-Grade 3
2.925600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.007500E-02
Grade 1-vs-Grade 3
9.483600E-02
Grade 1-vs-Grade 4
6.424200E-01
Grade 2-vs-Grade 3
9.100200E-01
Grade 2-vs-Grade 4
2.429400E-01
Grade 3-vs-Grade 4
2.925600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.989200E-01
Normal-vs-NonDiabetic
6.871400E-01
Diabetic-vs-NonDiabetic
8.743800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.499600E-01
Normal-vs-NoPancreatitis
7.200400E-01
Pancreatitis-vs-NoPancreatitis
9.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.187600E-01
Normal-vs-N1
8.472200E-01
N0-vs-N1
8.228600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.559200E-01
Normal-vs-TP53-NonMutant
7.794200E-01
TP53-Mutant-vs-TP53-NonMutant
1.468370E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
